Related Experiment Videos
Update on locally advanced breast cancer
1University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA. sgiordan@mdanderson.org
The Oncologist
|December 6, 2003
Summary
Locally advanced breast cancer (LABC) often metastasizes despite treatment. Prognosis for LABC varies, necessitating multimodal therapy and coordinated care for optimal outcomes.
Area of Science:
- Oncology
- Breast Cancer Research
Background:
- Locally advanced breast cancer (LABC) presents a significant clinical challenge, with many patients developing distant metastases even after treatment.
- LABC encompasses diverse clinical situations, including advanced primary tumors (T4), extensive lymph node involvement, and inflammatory breast cancer.
Purpose of the Study:
- To discuss the epidemiology, evaluation, prognostic factors, and treatment strategies for locally advanced breast cancer.
- To review inflammatory breast cancer as a distinct entity due to its unique biology and clinical behavior.
Main Methods:
- Review of epidemiological data.
- Analysis of prognostic factors.
- Discussion of current treatment modalities and planning.
Main Results:
- Prognosis in LABC is heterogeneous, influenced by tumor size, lymph node status, and inflammatory features.
- Multimodal therapy and interdisciplinary collaboration are crucial for managing LABC.
Conclusions:
- Effective management of locally advanced breast cancer requires a comprehensive approach.
- Understanding distinct disease subtypes, like inflammatory breast cancer, is vital for tailored treatment.